Search results
Results from the WOW.Com Content Network
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, India.It was founded by Kiran Mazumdar-Shaw in 1978. [4] The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, [5] including the United States and Europe. [4]
In December 2016, 20 American attorneys general filed a civil complaint accusing Aurobindo Pharma of a coordinated scheme to artificially maintain high prices for a generic antibiotic and diabetes drug. The complaint alleged price collusion schemes between six pharmaceutical firms including informal gatherings, telephone calls, and text ...
Kiran Mazumdar-Shaw (born 23 March 1953) is an Indian billionaire entrepreneur. [3] She is the executive chairperson and founder of Biocon Limited and Biocon Biologics Limited, [4] a biotechnology company based in Bangalore, India [5] and the former chairperson of Indian Institute of Management, Bangalore. [6]
For premium support please call: 800-290-4726 more ways to reach us
The NIFTY Next 50 is a stock market index provided and maintained by NSE Indices.It represents the next rung of liquid securities after the NIFTY 50.It consists of 50 companies representing approximately 10% of the traded value of all stocks on the National Stock Exchange of India.
From January 2011 to December 2012, if you bought shares in companies when Rayford Wilkins, Jr. joined the board, and sold them when he left, you would have a 43.7 percent return on your investment, compared to a 12.1 percent return from the S&P 500.
No-penalty CDs and savings accounts are low-risk investments that offer a safe way to grow your money while earning interest. Here's how to match your cash to the best savings strategy for you.
The demand is the number of shares investors wish to buy at exactly that same time. The price of the stock moves in order to achieve and maintain equilibrium. The product of this instantaneous price and the float at any one time is the market capitalization of the entity offering the equity at that point in time.